MTPAP Gene Spastic Ataxia Type 4 Autosomal Recessive Genetic Test sale cost 4400 AED
PC Gene Pyruvate Carboxylase Deficiency Genetic Test sale cost 4400 AED PC Gene Pyruvate Carboxylase Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
PLP1 Gene SPG2 Genetic Test sale cost 4400 AED PLP1 Gene SPG2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MTPAP Gene Spastic Ataxia Type 4 Autosomal Recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MTPAP Gene Spastic Ataxia Type 4 Autosomal Recessive Genetic Test” is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the MTPAP gene. These mutations are responsible for causing Spastic Ataxia Type 4, a rare autosomal recessive neurodegenerative disorder. This condition is characterized by a combination of spasticity and ataxia, affecting an individual’s motor skills and coordination. The test is crucial for individuals with a family history of the disorder or presenting symptoms, as it provides definitive genetic evidence of the condition. The cost of the test is 4400 AED, making it a valuable investment for those seeking accurate diagnosis and subsequent management or genetic counseling based on the results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MTPAP Gene Spastic Ataxia Type 4 Autosomal Recessive Genetic Test

Cost: AED 4400.0

Symptoms and Diagnosis

Spastic ataxia type 4 is a neurological disorder associated with the MTPAP gene. It is an autosomal recessive disorder, meaning that both copies of the gene must be mutated for an individual to develop the condition. Common symptoms of spastic ataxia type 4 include difficulty with coordination and balance, muscle stiffness, and speech difficulties.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre-Test Information

Before undergoing the MTPAP gene spastic ataxia type 4 genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to create a pedigree chart of family members affected by spastic ataxia type 4.

Test Details

The MTPAP gene is associated with spastic ataxia type 4, an autosomal recessive disorder. Next-Generation Sequencing (NGS) genetic testing is used to analyze multiple genes simultaneously. In the case of spastic ataxia type 4, NGS genetic testing can identify mutations in the MTPAP gene that may be responsible for the condition.

The test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the MTPAP gene. The results of the test can confirm a diagnosis of spastic ataxia type 4 and provide information about the specific genetic mutation involved.

It is important to note that genetic testing for spastic ataxia type 4 should be performed in a clinical setting by a healthcare professional or genetic counselor. They can help interpret the results, provide guidance on further testing, treatment options, and family planning considerations.

Test Name MTPAP Gene Spastic ataxia type 4 autosomal recessive Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MTPAP Gene Spastic ataxia type 4, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MTPAP Gene Spastic ataxia type 4, autosomal recessive
Test Details

The MTPAP gene is associated with spastic ataxia type 4, which is an autosomal recessive disorder. Autosomal recessive means that an individual must inherit two copies of the mutated gene, one from each parent, to develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of spastic ataxia type 4, NGS genetic testing can be used to identify mutations in the MTPAP gene that may be responsible for the condition.

The test involves obtaining a DNA sample, usually through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the MTPAP gene. The results of the test can help confirm a diagnosis of spastic ataxia type 4 and provide information about the specific genetic mutation involved.

It is important to note that genetic testing for spastic ataxia type 4 is typically performed in a clinical setting by a healthcare professional or genetic counselor. They can help interpret the results and provide guidance on any necessary further testing, treatment options, and family planning considerations.

SKU: TEST-1983 Category:

Related products